Regenerative Medicine in Atlanta.

Whether you have coverage depends on your plan and on the particular service, since there are two distinct services here.

First, there is an evaluation consisting of the office visit, examination, and any ordered tests including imaging studies; coverage for this part of the encounter follows the usual orthopedic benefits.

Second, there is the biologic procedure which has its own coverage criteria, and plans vary widely as to how they categorize these procedures.

No biologic can even be planned without a specific diagnosis, so the evaluation comes first regardless of what coverage exists for any later procedure. Your first phone call should ask about the orthopedic visit, not the biologic.

Before scheduling, call the member services number listed on the back of your insurance card. Ask whether a referral is required to see an orthopedic specialist. Ask whether imaging requires pre-authorization. And ask how the plan categorizes the specific procedure by name, since the answer will vary for each biologic. Request that information in writing if possible.

There is one more question you should ask during this phone call, though it is not strictly an insurance question. Ask whether the specific product is approved for the intended application. It could instead be investigational, or sold through another mechanism. A registered study, an entry in a clinical trials registry, and FDA approval to sell are all separate concepts. Adjectives such as "natural" and "cellular" are not relevant. Bring what you learn to the visit: when you request an appointment, the benefit question is already answered before treatment ever comes up. If a plan puts a biologic outside its benefits, that is information worth having early, because it shapes the conversation you and your surgeon will have.

These are choices, not cures for every aching joint. It depends on your precise diagnosis, the tissue being treated, what you hope to achieve, and what the data suggests will work for those factors. That's intentional. A treatment marketed as fixing everything attracts patients who never got a diagnosis.

The order never changes: a diagnosis first, built on history, exam, and imaging likely to alter the plan. Next come the standard options: exercise, modifications to activity and load, braces, surgery if the anatomy requires it. A biologic is added as one component of the overall plan, with a defined objective and a reassessment timepoint.

What are we trying to achieve? That question keeps things real. These products are evaluated on symptom reduction and functional improvement. Enhancing healing after a surgical procedure is another thing altogether with a different set of data. And neither should be taken as predictive of what an MRI will reveal down the road. Mixing up those ideas helped give this discipline its reputation. The biologic's role inside the larger strategy is a joint preservation answer to a joint preservation question: keep the native joint as long as possible, and reach for the option that honors the tissue rather than the one that sounds most sophisticated. That is not a product list; it is experience. Nearly two decades of orthopedic surgical practice shaped by professional sports medicine experience. Authored more than 15 peer-reviewed publications.

Atlanta patients often arrive having read a great deal about orthobiologics, yet no one has ever explained the differences between one product and another. Much of a first visit goes to sorting exactly that. If you want to know whether any of it applies to your diagnosis, request an appointment and start with the examination.